If you're hunting for dividend stocks that deliver killer total returns over the long haul, there are plenty of opportunities to consider right now. ...

Information about the risks associated with investing in Astrana Health, Inc. is included in the filings with the Securities and Exchange Commission, which we encourage you to review before any investment decisions. The company does not assume any obligation to update any forward-looking statements as a result of new information, future events, change in market conditions or otherwise, except as required by law. Regarding the disclaimer language, I would like you to refer to Slide Two of this conference cal ...

Key Takeaways CRAI beat Q4 estimates as revenues rose 11.6% year over year and EPS reached $2.06.CRAI posted 78% utilization, 1.4% headcount growth and $24.4M in non-GAAP EBITDA.CRAI guides 2026 revenues of $785-$805M and non-GAAP EBITDA margin of 12%-13%.Charles River Associates (CRAI) reported impressive fourth-quarter 2025 results, with earnings and revenues beating the Zacks Consensus Estimate. CRAI’s board expanded the share repurchase authorization by $55 million.The better-than-expected results, coup ...

Key Takeaways REGN and Sanofi received CHMP support to expand Dupixent for CSU in children aged 2-11 years.Phase III studies showed Dupixent cut itch and hives, and improved disease control at 24 weeks.Dupixent posted $17.8B in 2025 sales for Sanofi, while REGN logged $5.9B in collaboration revenues.Regeneron Pharmaceuticals (REGN) and its partner Sanofi (SNY) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recomme ...

Urogen Pharma (URGN) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to a loss of $0.8 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.18%. A quarter ago, it was expected that this company would post a loss of $0.72 per share when it actually produced a loss of $0.69, delivering a surprise of +4.17%.Over the last four quarters, the company has surpasse ...

Opening Bell: A Sea of Red Amid Global UncertaintyThe U.S. stock market opened sharply lower on Monday, March 2nd, 2026, as investors reacted to a dramatic escalation of geopolitical tensions in the Middle East over the weekend. Major market indexes saw significant downward pressure immediately following the opening bell. The S&P 500 (SPY) fell approximately 1.18%, trading near the 6,798 level, while the tech-heavy Nasdaq Composite (QQQ) led the decline with a 1.46% drop. The Dow Jones Industrial Average (D ...

PresentationCharles PetersRaymond James & Associates, Inc., Research Division Welcome to the Raymond James Institutional Investors Conference. I guess this is the 47th Annual Conference. So it's going to be a great year. I'm Greg Peters, I'm the insurance analyst for Raymond James. And it is an honor to welcome back Allstate to our conference. They've been a consistent participant in our conference for many years now, and we certainly appreciate and value their participation. From the management team of All ...

Defense stocks are in focus today, following news that the U.S. and Israel attacked Iran over the weekend, with missile strikes killing Supreme Leader Ayatollah Ali Khamenei. In response, Iran promised retaliation and also threatened to disrupt the Strait of Hormuz. The shares of Lockheed Martin Corp (NYSE:LMT) were last seen up 4.4% to trade at a fresh record high of $692, while also sporting a 40% year-to-date lead. The stock is on pace for its biggest single-day percentage gain in over a month, with rece ...

wildpixel/iStock via Getty Images All the major asset classes are posting year-to-date gains as of Friday’s close. But a lot can happen over one weekend. The US-Israel military strike on Iran is ongoing and appears set to continue for ...

Philadelphia, Pennsylvania--(Newsfile Corp. - March 2, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) ("CoreWeave" or the "Company") on behalf of investors who purchased or otherwise acquired CoreWeave securities during the period from March 28, 2025 through December 15, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased CoreWeave securities during the Class Period may, no late ...